We are excited to announce the opening of our new biomanufacturing facility in Greater Vancouver! This new facility, which was made possible through funding by the Government of Canada and the Government of British Columbia, is built to meet the higher regulatory compliance standard necessary to manufacture products that our customers use to support their clinical trials in the rapidly evolving fields of cell therapy, tissue engineering, immunotherapy, gene therapy, and regenerative medicine—all of which aim to cure cancer and other serious diseases.
We are proud that we have been selected as a winner of Deloitte Canada’s #BestManaged Companies program for the sixth year in a row. Congratulations to all our fellow winners!
